Login
Résultat de la recherche (1-20 par 66)Download
|
Symbol
|
RMA72V | RMBQ5V | RMA7JV | RMBAIV | ABUBTQ | RMAHCV | CMDBKB | RMAWUV | POARCH | POTRCH | Z0AQXZ | ACGFTQ | RMBV1V | RMALFV | Z0AU9Z | RMACWV | RMAXAV | RMBEPV | RMALNV | Z0B70Z |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible with European Knock-In | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible with European Knock-In | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Novartis AG / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Ypsomed Hldg. AG | Alcon / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Givaudan / Holcim/Amrize Basket / Nestlé S.A. / Ypsomed Hldg. AG | Bachem Hldg. AG / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Straumann Hldg. AG / VAT Group / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Sonova Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / VAT Group / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Sandoz Group AG / Ypsomed Hldg. AG | Novo Nordisk AS (B) / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Novartis AG / Roche PS / Straumann Hldg. AG / Ypsomed Hldg. AG | Galderma Group AG / Galenica AG / Ypsomed Hldg. AG | Aryzta AG / Flughafen Zürich AG / Sulzer AG / Ypsomed Hldg. AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
31.08.2026 | 17.11.2026 | 21.12.2026 | 30.12.2026 | 30.12.2026 | 06.07.2026 | 17.07.2026 | 25.01.2027 | 31.07.2026 | 07.08.2026 | 19.08.2027 | 03.09.2026 | 01.03.2027 | 28.08.2026 | 03.09.2027 | 31.03.2027 | 12.10.2026 | 07.12.2026 | 07.12.2026 | 18.12.2026 |
| Demande | 87,50 | 46,110 | 99,30 | 56,59 | 99,53 | - | 101,69 | 99,30 | 101,57 | 65,44 | - | 72,27 | 98,90 | 100,40 | - | 98,90 | 78,05 | 96,00 | 98,60 | - |
| Offre | - | - | 100,90 | - | 100,33 | - | - | 100,90 | - | - | - | - | 100,30 | 101,80 | - | 100,30 | - | - | 100,00 | - |
S'il vous plait attendre
Le push de données de prix a été désactivé en raison d'un timeout. S'il vous plaît cliquez sur "Actualiser la page" pour continuer.
Votre mémo (0)